文献速递消化系统肿瘤

全腹腔镜与腹腔镜辅助同期切除结直肠癌肝转移的比较研究

[A comparative study of total laparoscopic and laparoscopic-assisted simultaneous resection for colorectal cancer liver metastasis].
PubMed 文献 · Zhonghua Zhong Liu Za Zhi · 2020-01-01

该研究回顾性分析2008年12月至2016年12月行全腹腔镜或腹腔镜辅助同期切除的结直肠癌肝转移患者,经倾向性评分1∶2匹配后全腹腔镜组22例、腹腔镜辅助组44例。两组术中情况及术后并发症、住院时间、排便时间及无病生存和总生存差异均无统计学意义,结论认为两种术式安全性和近远期疗效接近,应根据患者病情和术者习惯选择合理术式。

要点

  • 全腹腔镜与腹腔镜辅助同期切除结直肠癌肝转移的术中情况和术后恢复指标差异无统计学意义。
  • 全腹腔镜组未发生Clavien-Dindo Ⅱ级及以上并发症,但两组总体并发症发生率差异无统计学意义。
  • 两组中位无病生存和总生存差异无统计学意义,术式选择应结合患者病情和术者经验。

核心结论

  • 全腹腔镜与腹腔镜辅助同期切除结直肠癌肝转移的安全性和近远期疗效接近,应根据患者病情和术者习惯选择合理术式。

研究设计与样本

  • 回顾性收集2008年12月至2016年12月于中国医学科学院肿瘤医院肝胆外科行全腹腔镜或腹腔镜辅助同期切除术的结直肠癌肝转移患者临床资料。
  • 采用倾向性评分法对全腹腔镜组和腹腔镜辅助组进行1∶2匹配,得到全腹腔镜组22例、腹腔镜辅助组44例。
  • 比较两组术中情况和术后效果。

主要发现

  • 两组术前基线资料差异均无统计学意义(均P>0.05)。
  • 全腹腔镜组和腹腔镜辅助组中位手术时间分别为317.50和267.50 min,中位出血量分别为100和200 ml,差异均无统计学意义(均P>0.05)。
  • 全腹腔镜组术中输血1例,腹腔镜辅助组术中输血5例,发生率差异无统计学意义(P=0.650)。
  • 全腹腔镜组和腹腔镜辅助组中位术后住院时间分别为11.0和10.0 d,中位术后排便时间均为4.0 d,术后并发症发生率分别为13.6%和20.5%,差异均无统计学意义(均P>0.05),但全腹腔镜组未发生Clavien-Dindo Ⅱ级及以上并发症。
  • 全腹腔镜组和腹腔镜辅助组中位无病生存时间分别为15.0和15.7个月,中位总生存时间分别为25.9和37.6个月,差异均无统计学意义(均P>0.05)。

临床怎么用

  • 对于同时性结直肠癌肝转移患者,全腹腔镜与腹腔镜辅助同期切除均可作为可选术式。
  • 术式选择应结合患者临床病情和术者技术经验进行个体化决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To compare the safety and outcome between total laparoscopic and laparoscopy-assisted synchronous resection for colorectal cancer patients with liver metastases. Methods: The data of patients who underwent total laparoscopic or laparoscopy-assisted simultaneous resection of primary colorectal cancer and liver metastases in our hospital between December 2008 and December 2016 were collected and analyzed. The total laparoscopic surgery patients were matched 1∶2 to the laparoscopy-assisted surgery patients based on the propensity score. 22 patients were classified in the total laparoscopic group and 44 patients were classified in the laparoscopy-assisted group. The intraoperative conditions and postoperative outcomes of the two groups were compared. Results: There was no difference in the preoperative baseline data between the two groups (P>0.05). The median operative time were 317.50 and 267.50 minutes in the total laparoscopic group and the laparoscopy-assisted group, respectively, and the median intraoperative blood loss were 100 and 200 ml, both with no statistically significant differences (P>0.05). There were 1 case of intraoperative blood transfusion in the total laparoscopic group and 5 cases in the laparoscopy-assisted group, with no statistically significant difference (P=0.650). The median postoperative hospital stay in the two groups were 11.0 and 10.0 days, the median postoperative defecation time were 4.0 and 4.0 days and postoperative complication rates were 13.6% and 20.5%, and none of these differences were statistically significant (P>0.05). However, no Clavien-DindoⅡ level and above complications occurred in total laparoscopic group. The median disease-free survival (DFS) were 15.0 and 15.7 months in the total laparoscopic group and the laparoscopy-assisted group, the overall survival (OS) were 25.9 and 37.6 months, respectively, with no statistically significant differences (P>0.05). Conclusion: Laparoscopy-assisted approaches are similar, so the appropriate approach should be chosen according to the clinical condition and surgeon's experience. 目的: 比较同时性结直肠癌肝转移(CRLM)患者行全腹腔镜与腹腔镜辅助同期切除手术的安全性和有效性。 方法: 收集2008年12月至2016年12月于中国医学科学院肿瘤医院肝胆外科行全腹腔镜或腹腔镜辅助同期切除术的CRLM患者的临床资料,根据倾向性评分法对全腹腔镜组和腹腔镜辅助组进行1∶2匹配,得到全腹腔镜组22例、腹腔镜辅助组44例,比较两组的术中情况和术后效果。 结果: 两组患者术前基线资料差异均无统计学意义(均P>0.05)。全腹腔镜组和腹腔镜辅助组的中位手术时间分别为317.50和267.50 min,中位出血量分别为100和200 ml,差异均无统计学意义(均P>0.05)。全腹腔镜组术中输血1例,腹腔镜辅助组术中输血5例,发生率差异无统计学意义(P=0.650)。全腹腔镜组和腹腔镜辅助组患者的中位术后住院时间分别为11.0和10.0 d,中位术后排便时间均为4.0 d,术后并发症发生率分别为13.6%和20.5%,差异均无统计学意义(均P>0.05),但全腹腔镜组未发生Clavien-Dindo Ⅱ级及以上并发症。全腹腔镜组和腹腔镜辅助组患者的中位无病生存时间分别为15.0和15.7个月,中位总生存时间分别为25.9和37.6个月,差异均无统计学意义(均P>0.05)。 结论: 全腹腔镜与腹腔镜辅助结直肠癌同期切除术的安全性和近远期疗效接近,应根据患者病情和术者习惯选择合理术式。.

来源:Zhonghua Zhong Liu Za Zhi,查看原文。版权归原作者所有。

引用

  1. Li XC, Li ZY, Luo ZW, et al. [A comparative study of total laparoscopic and laparoscopic-assisted simultaneous resection for colorectal cancer liver metastasis]. Zhonghua Zhong Liu Za Zhi. 2020. PMID: 32482032. doi:10.3760/cma.j.cn112152-112152-20190814-00526

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。